Ann: CBD Products to Become Available Over the Counter, page-52

Did you read the article?
It sure looks like you didn't digest the following:

-----------------------------------------------------------

"Some of the products of concern were manufactured in Australia and underwent local batch testing by a TGA-approved laboratory. But when tested by the TGA themselves these products were found to be non-compliant.The results highlight the scientific and technical challenges of product consistency and analytical accuracy."

Also:

"Althea chief executive Josh Fegan said the products named in the report “underwent extensive testing” prior to release, including pre-importation testing in Canada using independent laboratories and post-importation analysis in Australia using NATA ISO/IEC accredited labs. “With respect to the products listed in the TGA report, prior to release Althea received results confirming the CBD content was within the tolerance of the required standard,” he said.

“These test results were further confirmed post release as part of Althea’s routine rotational testing protocol. Althea CEO Josh Fegan: pre and post-import tests were within the required standard“ In the light of this, Althea is currently in dialogue with the TGA regarding findings published in this report. We appreciate the fact that in the absence of a nationally accepted pharmacopeial standard for medicinal cannabis, interlaboratory variances will occur, and we look forward to clarifying the results with the TGA.

“We otherwise note that the TGA did not require Althea to take any action with respect to the products.” On the apparent discrepancies between the declaration and labelling, Fegan said: “To date, with products imported from Canada, in addition to information submitted to the TGA, batch-specific concentrations are printed on the product label. The TGA is aware of this practice and has no issue with it.”